Swiss ministers have met with senior executives of pharmaceutical companies Roche and Novartis to discuss the outlook for the ...

To navigate the post-LDC era successfully, Bangladesh must transition from a volume-driven, generics-dominated model to one ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

India had refused accept demands from the UK and Switzerland for data exclusivity to protect generic pharma industry, with ...

India and China are set to discuss a trade package focusing on essential commodities like rare earth magnets, fertilizers, ...

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

Apertura Gene Therapy has entered several licensing agreements to advance CNS treatments using its TfR1 CapX technology.

Swiss ministers met with senior executives from Roche and Novartis to discuss the potential impact of U.S. import tariffs on pharmaceuticals. While pharmaceuticals currently avoid these tariffs, an ...

No additional tariffs have been imposed on Indian exports to the United States in key sectors such as pharmaceuticals and ...

Citing other priorities—such as the upcoming U.S.-Russia summit—four anonymous sources claim that pharma tariffs could still ...